ChampionX Corporation [NYSE: CHX] price surged by 1.37 percent to reach at $0.2. The company report on December 14, 2020 that ChampionX Corporation Announces Early Tender Offer Results and Extension of Early Tender Premium.
ChampionX Corporation (NYSE: CHX) (the “Company” or “ChampionX”) announced that, pursuant to the Company’s previously announced cash tender offer (the “Tender Offer”) with respect to the securities described in the table below (the “Notes”), the principal amount of Notes that were validly tendered and not validly withdrawn on or before 5:00 p.m., New York City time, on December 11, 2020 (the “Early Tender Date”), according to information provided by D.F. King & Co., Inc., the tender agent for the Tender Offer, and the principal amount of Notes to be accepted for purchase by the Company in accordance with the terms of the Tender Offer, are as set forth in the table below. Because the withdrawal deadline relating to the Tender Offer expired at 5:00 p.m., New York City time, on December 11, 2020, these Notes, as well as any subsequently tendered Notes, may not be withdrawn.
The terms and conditions of the Tender Offer are described in detail in the Offer to Purchase, dated as of November 30, 2020 (the “Offer to Purchase”). Holders are encouraged to read the Offer to Purchase carefully.
A sum of 3340801 shares traded at recent session while its average daily volume was at 1.88M shares. ChampionX Corporation shares reached a high of $14.83 and dropped to a low of $14.12 until finishing in the latest session at $14.75.
The one-year CHX stock forecast points to a potential upside of 7.29. The average equity rating for CHX stock is currently 1.80, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on ChampionX Corporation [CHX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CHX shares is $15.91 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CHX stock is a recommendation set at 1.80. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Cowen have made an estimate for ChampionX Corporation shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on October 30, 2020. While these analysts kept the previous recommendation, Scotiabank raised their target price to Sector Outperform. The new note on the price target was released on September 16, 2020, representing the official price target for ChampionX Corporation stock. Previously, the target price had yet another raise to $13, while Credit Suisse analysts kept a Outperform rating on CHX stock.
The Average True Range (ATR) for ChampionX Corporation is set at 0.84, with the Price to Sales ratio for CHX stock in the period of the last 12 months amounting to 2.06. The Price to Book ratio for the last quarter was 1.84, with the Price to Cash per share for the same quarter was set at 0.85. Price to Free Cash Flow for CHX in the course of the last twelve months was 16.35 with Quick ratio for the last quarter at 1.30.
CHX Stock Performance Analysis:
ChampionX Corporation [CHX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 9.50. With this latest performance, CHX shares gained by 28.26% in over the last four-week period, additionally plugging by 51.13% over the last 6 months – not to mention a drop of -50.73% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CHX stock in for the last two-week period is set at 68.43, with the RSI for the last a single of trading hit 70.48, and the three-weeks RSI is set at 66.79 for ChampionX Corporation [CHX]. The present Moving Average for the last 50 days of trading for this stock 10.64, while it was recorded at 14.22 for the last single week of trading, and 9.42 for the last 200 days.
Insight into ChampionX Corporation Fundamentals:
ChampionX Corporation’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.30 and a Current Ratio set at 2.10.
CHX Stock EPS
With the latest financial reports released by the company, ChampionX Corporation posted 0.13/share EPS, while the average EPS was predicted by analysts to be reported at 0.14/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -7.10%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CHX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for ChampionX Corporation go to -12.63%.
ChampionX Corporation [CHX] Insider Position Details
There are presently around $2,945 million, in the hands of institutional investors. The top three institutional holders of CHX stocks are: BLACKROCK INC. with ownership of 21,220,658, which is approximately -7.931% of the company’s market cap and around 0.10% of the total institutional ownership; VANGUARD GROUP INC, holding 18,821,182 shares of the stock with an approximate value of $277.61 million in CHX stocks shares; and BOSTON PARTNERS, currently with $185.63 million in CHX stock with ownership of nearly 25.013% of the company’s market capitalization.
132 institutional holders increased their position in ChampionX Corporation [NYSE:CHX] by around 24,783,956 shares. Additionally, 152 investors decreased positions by around 23,567,336 shares, while 52 investors held positions by with 151,282,221 shares. The mentioned changes placed institutional holdings at 199,633,513 shares, according to the latest SEC report filing. CHX stock had 39 new institutional investments in for a total of 3,419,747 shares, while 48 institutional investors sold positions of 5,149,406 shares during the same period.